Ruben Mesa: Honored to Have Been The Senior Author of The Plenary Abstract of the Phase III SURPASS-ETs Trial at EHA25

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared a post on LinkedIn:

“Honored to have been the senior author of this Plenary Abstract at EHA25 (presented by great colleague Harry Gill, The University of Hong Kong ) of the Phase III SURPASS ET trials showing Superiority of ROPEG over ANAGRELIDE in 2L for Essential Thrombocythemia”